Purchase Order 75N90025P00053

Award Date 10/29/24
Potential Completion Date 9/30/25
Potential Value $25K
Federal Agency
NIH Clinical Center
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sugar Land, TX 77478, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $100,000.00 firm-fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Quva Pharma, Inc., a for-profit organization located in Sugar Land, Texas. The contract is for the delivery of specialized sterile compounded pharmaceutical products, including patient-controlled analgesia systems, epidural products, and other critical medical preparations to support the NIH Clinical Center's pain management initiatives and clinical research needs....
This is a firm fixed price delivery order awarded by the Department of Health and Human Services' National Institutes of Health Clinical Center to Quva Pharma, Inc., a 503B outsourcing facility that provides sterile compounded pharmaceutical products to federal agencies. The contract is for outsourcing patient-controlled analgesia systems (PCACs) and epidurals, with a potential value of $250,000.00 and a completion date of September 30, 2024. Quva Pharma has previously held prime federal...
This is a $231,100.12 firm fixed price purchase order contract awarded by the Department of the Army Medical Command to Quva Pharma, Inc., a for-profit 503B outsourcing facility that provides sterile compounded pharmaceutical products. The contract is set aside for small businesses and covers the delivery of compounded pharmaceuticals to support the Army's medical operations. Quva Pharma has previously held other federal contracts to provide sterile compounding services, patient-controlled...
This is a firm fixed-price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Quva Pharma, Inc., a small business contractor. The contract, valued at $95,227.80, is for the delivery of compounded pharmaceutical products to the Carl R. Darnall Army Medical Center at Fort Hood, Texas. The contract was set aside for small business contractors and has an ultimate completion date of September 30, 2019. Quva Pharma is a 503B outsourcing facility that specializes in providing sterile...
This is a firm-fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center, a civilian agency, to Tri-Pharma, Inc., a minority-owned, Hispanic American-owned small disadvantaged business corporation. The $15,500 contract is for the delivery of pharmaceutical and medical supply products, including items like SANDOSTATIN, RYDAPT, fludarabine, ranitidine, and personal protective equipment such as N95 masks, surgical masks, and disinfectant wipes. The...
The National Institutes of Health (NIH) Clinical Center awarded a $249,975.51 firm-fixed-price purchase order to VWR International LLC for pharmacy current Good Manufacturing Practice (cGMP) cleaning supplies. The contract, which does not have a set-aside designation, will run from June 27, 2025, through June 26, 2026, with delivery to the NIH's Bethesda, Maryland campus. VWR International, a for-profit manufacturer and supplier of laboratory equipment and medical supplies, was selected as the...
This is a $1,264.86 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of QUVIVIQ 50 MG TABLET 30S, a pharmaceutical product, with a performance period ending on March 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Quintara Discovery, Inc. for bioanalysis testing services. The contract has a ceiling value of $129,750.00 and a completion date of October 25, 2015. The contract was not set aside for any special designation. Quintara Discovery, Inc. is a for-profit organization that is foreign-owned. The contract does not appear to be associated with a larger vehicle, and no...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of QUVIVIQ 50 MG TABLET 30S, a prescription drug, with a ceiling value of $5,212.24 and a completion date of October 9, 2024. The contract is a firm-fixed-price delivery order, which means AmerisourceBergen will provide the specified pharmaceutical product at a predetermined price. This contract is not...
This $27,610.40 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 to QOL Medical LLC. To be completed by December 14, 2022, the firm fixed price order is for emergency procurement of the prescription medication Sucraid. Placed under Schedule 61-IB and with performance in Vero Beach, Florida, this award continues the VA's efforts to provide critical...

This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Quva Pharma, Inc., a for-profit organization located in Sugar Land, Texas. The contract, valued at $25,000.00, is for the delivery of sterile intravenous medications, patient-controlled analgesia systems, and epidural products to support the NIH Clinical Center's pain management initiatives and clinical research needs. The contract has an ultimate completion date of September 30, 2025 and was awarded on October 29, 2024. This contract is not associated with a set-aside designation and represents a sole-source acquisition, recognizing Quva Pharma's specialized capabilities in providing compounded pharmaceutical products to federal healthcare agencies. Quva Pharma has a history of delivering similar services to the NIH Clinical Center, Department of Veterans Affairs, Defense Health Agency, and Department of the Army Medical Command through previous contract awards.

Generated 8/3/25, 1:08 AM